Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
4 papers
Recent·Most cited
K. A. Afanou, S. Mundra, E. L. Estensmo, I. Pedersen, J. R. Liland, E. Eriksen, P. Graff, T. T. Hildre, K.-C. Nordby, A. Straumfors
The paper investigates how fungal spore levels and species diversity in dust from waste-sorting plants affect TLR2 and TLR4-mediated NFkB activation.
bioRxiv · Oct 10, 2022Microbiology
H. Guzman, K. Sanders, A. Idica, A. Bochnakian, D. Jury, I. Daugaard, D. G. Zisoulis, I. Pedersen
This paper identifies miR-128 as a novel telomerase inhibitor that directly targets TERT mRNA, reducing its expression in cancer cell lines.
bioRxiv · Oct 6, 2017Cancer Biology
I. Pedersen, A. Bochnakiem, D. Zisoulis, A. Idica, A. Zhen, V. KewalRamani, I. Daugaard, M. Hamdorf, S. Kitchen, K. Lee
This study shows that miR-128 inhibits HIV-1 replication by targeting TNPO3 mRNA, reducing its expression and affecting viral spread.
bioRxiv · Sep 28, 2017Cell Biology
A. Idica, E. Sevrioukov, D. Zisoulis, M. Hamdorf, I. Daugaard, P. Kadandale, I. Pedersen
This study shows miR-128 represses L1 retrotransposition by both directly binding L1 RNA and downregulating TNPO1, a nuclear import factor.
bioRxiv · Sep 28, 2017Cell Biology